JRCT ID: jRCT2080224576
Registered date:27/02/2019
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 25/03/2019 |
Target sample size | 12 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | safety |
---|---|
Secondary Outcome | safety pharmacokinetics pharmacokinetics pharmacokinetics pharmacokinetics pharmacokinetics efficacy efficacy efficacy efficacy |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | Not applicable |
Gender | Female |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT03816839,JapicCTI-194645 |
Contact
Public contact | |
Name | |
Address | |
Telephone | +81-3-6301-3670 |
clinical-trials-jp@sanofi.com | |
Affiliation | |
Scientific contact | |
Name | |
Address | |
Telephone | +81-3-6301-3670 |
clinical-trials-jp@sanofi.com | |
Affiliation |